About 500mg Riturirel Rituximab Injection
| Strength |
500mg |
| Packaging Type |
Box |
| Packaging Size |
50ml |
| Brand |
Riturirel |
| Manufacturer |
Reliance |
| Composition |
Rituximab |
| Treatment |
Cancer |
Reditux 500 mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.
Reditux 500 mg Injection is give under the supervision of doctor. You must take it in a dose as advised by the doctor. The duration of treatment varies on the basis of your need and response to treatment. However, before taking it inform your doctor if you have any heart rhythm problems, if you are having surgery or if you plan to get any vaccinations. Your doctor may get blood tests done to check for hepatitis B before treatment and to check your blood cells during treatment with this medicine. You should inform doctor immediately if you notice any signs of infection such as fever, sore throat or rash.
Precisely Targeted TherapyRiturirel delivers targeted cancer and immunotherapy via monoclonal antibody action against CD20-positive B cells. This approach enhances efficacy while minimizing unwanted effects on healthy cells, making it suitable for adult patients with non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and specific autoimmune diseases. Rituximab's targeted mechanism provides improved disease control for suitable indications.
Safe and Professional AdministrationRiturirel must be prepared and administered by trained healthcare professionals under aseptic conditions. The lyophilized powder is reconstituted with sterile water and further diluted according to the product insert. Intravenous infusion is the sole route of administration, with dosage guided by indication and patient body surface area to ensure safe, effective treatment.
Strict Handling and Storage RequirementsStore Riturirel at 2C to 8C and protect it from light. Never freeze the vial. Proper handling, including correct disposal of unused medicine and waste, is essential and should follow local regulations. These precautions maintain product integrity and reduce the risk of accidental exposure or contamination.
FAQ's of 500mg Riturirel Rituximab Injection:
Q: How should Riturirel Rituximab Injection be prepared and administered?
A: Riturirel must be reconstituted with the provided sterile water for injection and diluted with the recommended IV solution as outlined in the product insert. It is administered exclusively by intravenous infusion under aseptic conditions by trained healthcare professionals.
Q: What are the primary uses and benefits of Riturirel Rituximab Injection?
A: Riturirel is indicated for adult patients with CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, certain autoimmune diseases like rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis. Its benefit lies in targeted therapy, which selectively attacks abnormal B cells while sparing healthy tissues.
Q: When is it not appropriate to use Riturirel Rituximab Injection?
A: This medication is contraindicated in individuals with known hypersensitivity to Rituximab or any component of the formulation, and in those with active severe infections. Always consult a healthcare provider to determine suitability.
Q: Where should Riturirel be stored, and what are key precautions?
A: Store Riturirel at 2C to 8C, away from light, and do not freeze. The product should be kept in its original packaging until use and handled according to local safety and disposal protocols to ensure safety and stability.
Q: What possible side effects should patients be aware of during treatment?
A: Common side effects include infusion-related reactions such as fever, chills, hypotension, infections, and neutropenia. Premedication with antihistamines and antipyretics is generally recommended to minimize infusion reactions.
Q: What is the process for using Riturirel and who can administer it?
A: Only a trained healthcare professional should prepare and administer Riturirel. The process involves reconstituting the lyophilized powder with sterile water, diluting it, and infusing it intravenously according to prescribed dosage and clinical guidelines.
Q: Why is premedication advised before administering Riturirel?
A: Premedicating with antihistamines and antipyretics helps reduce the risk and severity of infusion-related reactions, which can occur with administration of Rituximab.